Shares of Nasdaq-listed Helius Medical Technologies (HSDT) surged nearly 15% after the company announced a new lending program linked to staked Solana (SOL).
The company will now let institutions borrow against their staked SOL without selling or unstaking it. This move pushed investor interest higher, especially after the stock had touched record lows earlier this week.
How the Lending Program Works
HSDT partnered with Anchorage Digital and Kamino Finance to launch the program.
Institutions can keep their SOL staked, continue earning rewards, and still borrow funds. The assets remain in custody while firms access liquidity. Companies do not need to sell tokens to raise cash.
This setup helps institutions manage cash needs while holding long-term crypto investments.
Why It Matters Now
Solana’s price has fallen from highs near $245 to around $83 during the broader market correction. The drop has hurt companies that hold large SOL reserves.
HSDT remains well below levels seen before it shifted to a Solana treasury strategy. The recent stock jump reflects optimism about better capital management, not a full recovery in crypto prices.
Market Impact
Several SOL-focused firms are adjusting their approach. Some are increasing staking operations to earn steady rewards. Others are exploring additional income strategies.
The broader crypto market still faces pressure. However, companies continue building financial tools around staking and lending. Investors reacted positively to signs that institutions are improving risk management instead of exiting the space.
For now, the stock rally signals cautious confidence as firms look for ways to strengthen their position during a volatile market.
